These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 11550392)
1. A bloody mess. New safeguards will cut supplies of a lifesaving resource. Sobel RK US News World Rep; 2001 Sep; 131(8):36-9. PubMed ID: 11550392 [No Abstract] [Full Text] [Related]
2. Blood groups differ on donor deferral. Mitka M JAMA; 2001 Apr; 285(13):1694-5. PubMed ID: 11277807 [No Abstract] [Full Text] [Related]
3. Pressure grows over US blood ban. Goodman S Nature; 2001 Aug; 412(6846):467. PubMed ID: 11484010 [No Abstract] [Full Text] [Related]
4. FDA wants more restrictions on donated blood. Mitka M JAMA; 2001 Jul; 286(4):408. PubMed ID: 11466114 [No Abstract] [Full Text] [Related]
5. Informing a recipient of blood from a donor who developed Creutzfeldt-Jakob disease: the characteristics of information that warrant its disclosure. Steinberg D J Clin Ethics; 2001; 12(2):134-40. PubMed ID: 11642064 [No Abstract] [Full Text] [Related]
7. Bad blood. Newman RJ; Podolsky D; Loeb P US News World Rep; 1994 Jun; 116(25):68-70, 72-8. PubMed ID: 10134824 [No Abstract] [Full Text] [Related]
8. Comment: dilemmas of dementia. Dodd RY J Clin Ethics; 2001; 12(2):141-2. PubMed ID: 11642065 [No Abstract] [Full Text] [Related]
9. Current and emerging infectious risks of blood transfusions. Busch MP; Kleinman SH; Nemo GJ JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733 [No Abstract] [Full Text] [Related]
10. Rethinking blood shield statutes in view of the hepatitis C pandemic and other emerging threats to the blood supply. Rueda A J Health Law; 2001; 34(3):419-58. PubMed ID: 11571894 [TBL] [Abstract][Full Text] [Related]
11. Blood & politics. Titus K CAP Today; 1996 Mar; 10(3):20, 22-4. PubMed ID: 10160264 [No Abstract] [Full Text] [Related]
12. Progress in blood supply safety. Revelle M FDA Consum; 1995 Apr; 29(3):21-4. PubMed ID: 10141840 [No Abstract] [Full Text] [Related]
13. Keeping the U.S. blood supply safe. MLO Med Lab Obs; 2010 Jul; 42(7):14, 16. PubMed ID: 20690450 [No Abstract] [Full Text] [Related]
14. Revised precautionary measures to reduce the possible transmission of Creutzfeldt-Jakob disease (CJD) by blood and blood products; guidance document; availability--FDA. Notice. Fed Regist; 1997 Sep; 62(184):49694-5. PubMed ID: 10173801 [TBL] [Abstract][Full Text] [Related]
15. FDA seeks tighter rules on blood donors. Kaye D Clin Infect Dis; 2001 Oct; 33(8):i. PubMed ID: 11669068 [No Abstract] [Full Text] [Related]
17. [Importance of introduction of PCR in blood banks]. Gürtler L Infusionsther Transfusionsmed; 1996 Feb; 23(1):4-6. PubMed ID: 8653016 [No Abstract] [Full Text] [Related]
18. Review demanded on Canadian blood. Science; 1992 Dec; 258(5090):1878-9. PubMed ID: 1470910 [No Abstract] [Full Text] [Related]
19. Modeling the risk of an emerging pathogen entering the Canadian blood supply. Kleinman S; Cameron C; Custer B; Busch M; Katz L; Kralj B; Matheson I; Murphy K; Preiksaitis J; Devine D Transfusion; 2010 Dec; 50(12):2592-606. PubMed ID: 20553433 [TBL] [Abstract][Full Text] [Related]
20. Variant Creutzfeldt-Jakob disease and prions in the blood supply. Rohwer RG; Drohan W Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166 [No Abstract] [Full Text] [Related] [Next] [New Search]